Navigation Links
Scottsdale Facility to Be First in U.S. to Showcase True REST Technology
Date:6/16/2009

Research Shows Numerous Benefits Including Stress Reduction, Pain Relief and Improved Sleep Patterns

SCOTTSDALE, Ariz., June 16 /PRNewswire/ -- According to the American Medical Association, stress is a factor in more than 75 percent of illness today. The World Health Organization cites stress as America's No. 1 Health Problem. And the American Psychological Association calls stress a "major health problem." An Arizona entrepreneur, however, is launching a business that he hopes will send stress levels tumbling.

This summer, Nick Janicki will open a True REST Float Center in Scottsdale, Ariz. - the first of its kind in the U.S. In the United Kingdom, more than 300 of these types of centers are in operation, with hundreds more throughout Europe. REST stands for Restricted Environmental Stimulus Therapy, a name developed in the late 1970s by Peter Suedfeld and Roderick Borrie for a technique that had previously been called Sensory Deprivation (SD) or Sensory Isolation. The use of sensory restriction as an intervention that alters human consciousness actually began in 1951 at the McGill University Perceptual Isolation Laboratory.

Flotation REST involves floating on top of a pool of saltwater - 10 inches of water and 800 pounds of Epsom salt - in a specially designed tank with minimal light and sound. Because of the high salt content of the water, which is heated to skin surface temperature, a person is able to float effortlessly. The tanks are completely safe and clients of True REST can customize their experience with music and a multitude of light colors for ambiance.

"True REST is a state of complete relaxation," said Janicki. "It's a great way to escape the stresses of everyday life."

Flotation REST has been associated with the following benefits:

    -- Eliminates jet lag
    -- Improves sleep
    -- Quickens rehabilitation and recovery
    -- Relieves pain
    -- Boosts immunity
    -- Improves circulation
    -- Reduces blood pressure, pulse, heart rate and oxygen consumption
    -- Sharpens mental clarity and alertness

"The float tank is not a hypothetical laboratory phenomenon, but a viable, proven technology," according to Dr. Henry Adams of the National Institute of Mental Health.

Studies have shown REST to be effective in treating various eating disorders, in decreasing heavy drinking, and in treating a variety of other behavioral and mental health disorders. A University of Arizona study examined chamber REST as a relapse prevention technique for substance abusers enrolled in traditional outpatient treatment programs. At the end of four years of follow-up, 43 percent remained continuously sober and drug-free. None of the control group did so for eight months of follow-up.

Treatment in the form of floating in huge tanks of saltwater, so-called "floating," is effective for chronic stress-related pain, according to a study at Karlstad University, Sweden. Patients treated with floating suffered from long-term health problems. Several had been diagnosed with "burnout." After a seven-week treatment period, 22 percent of the participants in the floating group were entirely pain-free, and 56 percent experienced a clear improvement, reported the International Journal of Stress Management.

True REST sessions are priced on either a single session, monthly, twice a month or weekly rates. Group rates are available upon request. Reservations are being accepted now, with pre-opening discounts. For more information, visit http://www.true-rest.com.

About Nick Janicki

Nick Janicki has been a project manager/business analyst in both the IT field and commercial real estate industry. He also was an assistant manager of a retail store, giving him a rounded experience that led to his new role of Founder of True REST.

    Contact:

    Nick Janicki
    3939 S Illinois St
    Chandler, AZ 85248
    nick@true-rest.com
    602-481-3814
    Fax: 480-718-8305

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE True REST, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmateks Highly-Potent and Cytotoxic (HP/C) Facility Positions It as Industry Leader in Development and Manufacturing of HP/C Compounds
2. Micromet Expands Committed Equity Financing Facility to $75 Million
3. Isogen Launches Major New Facility to Address Global Biopharma Demand
4. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
5. Molecular Biometrics Hires Denny Sakkas, PhD Renowned Yale Embryologist and International Thought-Leader, as Chief Scientific Officer; Opening U.S. Research Facility
6. Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM)
7. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
8. WORLDS First Robotic Assisted Kidney Transplant Performed at Saint Barnabas Medical Center
9. Encouraging First Data on New Targeted Treatment for Patients With Melanoma - the Deadliest Form of Skin Cancer
10. Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting
11. Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Feb. 23, 2017  Directors from Pharma To Market Pty ... have joined forces, resulting in the founding of Pharma To Market ... Pharma To Market are pleased to announce their expansion into ... Singapore . The company are delighted to appoint ... of the Singapore based entity. Joelle brings ...
(Date:2/24/2017)...  Xynomic Pharmaceuticals, Inc., an oncology drug research ... acquired exclusive worldwide rights to develop, manufacture and ... targeting hematological and solid tumors. To ... 2 clinical trials of Abexinostat in US, EU ... been completed, demonstrating that Abexinostat is clinically active ...
(Date:2/23/2017)... SEOUL , Südkorea, 23. Februar 2017 ... LED für Sterilisationsaufgaben vorgestellt. Die Sterilisationsleistung beträgt das 1,5-fache ... kurzwellige ultraviolette Strahlung im Bereich zwischen 200 und 280 nm ... Ausbreitung von Bakterien, indem es ihre DNA zerstört. Das ... 280 nm. ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... ... Only two months after the official release of The Private Collection – Edition ... has initiated a second print-run of its lavish luxury travel coffee table book. ... weighs in at more than six kilos, retails at EUR 1,000 per copy and ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis ... University of Pittsburgh points to eight genes that may explain why susceptibility to one ... the results of a study published today in the journal npj Schizophrenia. , ...
(Date:2/24/2017)... ... February 24, 2017 , ... The Smart Machine Age is ... University predict that 47 percent of all jobs in the United States may be ... “successful.” The day of the aggressive know-it-all who steamrolls over colleagues is drawing to ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... and hearing disabilities, it is so critically important that we all are aware ... That is why Mediaplanet is proud to announce the launch of its newest ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal 8: An Australian ... account of his paramedic experiences. Schanssema describes the tragedies he saw, as well as ... overcome them. , Schanssema, initially unsure of the career path he wanted to take, ...
Breaking Medicine News(10 mins):